Gingival defects can be treated in multiple ways. The current gold standard is connective tissue graft (CTG) in order to treat Class I and II Miller defects (Chambrone, 2008). One of the newer procedures is the use of platelet-rich fibrin (PRF) therapy, which involves drawing the patient’s own blood and forming a membrane to heal gingival defects. This literature review looks at scholarly articles comparing the use of PRF to CTG in healing clinical attachment loss (CAL) over a period of 6 months and whether one is more effective than the other in gaining CAL.

Author: Stephanie Tu, Dental Hygiene Class of 2020

Dental Hygiene Award Winner

[embeddoc url="https://excellenceday.pacific.edu/wp-content/uploads/2020/06/Platelet-rich-fibrin.pdf" download="all"]